Differential expression of dysadherin in papillary thyroid carcinoma and microcarcinoma: Correlation with E-cadherin

Endocrine Pathology

Volumn 19, Issue 3, 2008, Pages 197-202

  Batistatou, Anna ^a   Charalabopoulos, Konstantinos ^a   Nakanishi, Yukihiro ^b   Vagianos, Constantine ^c   Hirohashi, Setsuo ^b   Agnantis, Niki J ^a   Scopa, Chrissoula D ^c  

^a UNIVERSITY OF IOANNINA   (Greece)

^b NATIONAL CANCER CENTER RESEARCH INSTITUTE   (Japan)

^c UNIVERSITY OF PATRAS   (Greece)

Author keywords

Dysadherin; E cadherin; Microcarcinoma; Papillary carcinoma; Thyroid

Indexed keywords

DYSADHERIN; UVOMORULIN; CADHERIN; FXYD5 PROTEIN, HUMAN; MEMBRANE PROTEIN; TUMOR PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; CELL ADHESION; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; METASTASIS; PAPILLARY CARCINOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; THYROID CARCINOMA; TRANSCRIPTION REGULATION; TUMOR CELL; TUMOR VOLUME; UTERINE CERVIX CARCINOMA; BIOSYNTHESIS; GENE EXPRESSION; METABOLISM; PATHOLOGY; THYROID FOLLICULAR CARCINOMA; THYROID TUMOR;

CADHERINS; CARCINOMA, PAPILLARY, FOLLICULAR; GENE EXPRESSION; HUMANS; IMMUNOHISTOCHEMISTRY; MEMBRANE GLYCOPROTEINS; NEOPLASM PROTEINS; THYROID NEOPLASMS;

EID: 58149268184     PISSN: 10463976     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12022-008-9035-1     Document Type: Article

References (39)

1. A Machens H-J Holzhausen H Dralle 2005 The prognostic value of primary tumor size in papillary and follicular thyroid carcinoma Cancer 203 2269 73
2. CD Scopa 2004 Histopathology of thyroid tumors. An overview Hormones 3 100 10
3. CD Scopa J Petrohilos J Spiliotis M Melachrinou 1993 Autopsy findings in clinically normal thyroids. A study in southwestern Greek population Int J Surg Pathol 1 25 32
4. ZW Baloch VA Livolsi 2006 Microcarcinoma of the thyroid Adv Anat Pathol 13 69 75
5. M Piersanti S Ezzat SL Asa 2003 Controversies in papillary microcarcinoma of the thyroid Endocr Pathol 14 183 91
6. AK Lak CY Lo KS Lam 2005 Papillary carcinoma of thyroid: a 30-yr clinicopathological review of the histological variants Endocr Pathol 16 323 30
7. J Rosai VA LiVolsi M Sobrinho-Simoes ED Williams 2003 Renaming papillary microcarcinoma of the thyroid gland: the Porto proposal Int J Surg Path 11 249 51
8. T Kondo S Ezzat SL Asa 2006 Pathogenetic mechanisms in thyroid follicular-cell neoplasia Nat Rev Cancer 6 292 306
9. MT Tetzlaff A Liu X Xu SR Master DA Balwin JW Tobias VA Livolsi ZN Baloch 2007 Differential expression of miRNAs in papillary thyroid carcinoma compared in formalin fixed paraffin embedded tissues Endocr Pathol 18 163 73
10. A Abrosimov V Saenko S Meirmarov M Nakashima T Rogounocitch O Shkurko E Lushnikov N Mitsutake H Namba S Yamashita 2007 The cytoplasmic expression of MUC1 in papillary thyroid carcinoma of different histological variants and its correlation with cyclin D1 overexpression Endocr Pathol 18 68 75
11. M Takeichi 1991 Cadherin cell adhesion receptors as a morphogenetic regulator Science 251 1451 5
12. K Charalabopoulos J Binolis S Karkabounas 2002 Adhesion molecules in carcinogenesis Exp Oncol 24 249 57
13. S Hirohashi Y Kanai 2003 Cell adhesion system and human cancer morphogenesis Cancer Sci 94 575 81
14. G Serini L Trusolino E Saggiorato O Cremona M De Rossi A Angeli F Orlandi PC Marchisio 1996 Changes in integrin and E-cadherin expression in neoplastic versus normal thyroid tissue J Natl Cancer Inst 88 442 9
15. R von Wasielewski A Rhein M Werner GF Scheumann H Dralle E Pötter G Brabant A Georgii 1997 Immunohistochemical detection of E-cadherin in differentiated thyroid carcinomas correlates with clinical outcome Cancer Res 57 2501 7
16. Y Kapran N Ozbey S Molvalilar E Sncer F Dizdaroglu S Ozarmagan 2002 Immunohistochemical detection of E-cadherin, alpha- and beta-catenins in papillary thyroid carcinoma J Endocrinol Invest 25 578 85
17. AS Rocha P Soares E Fonseca J Cameselle-Teijeiro MC Oliveira M Sobrinho-Simoes 2002 E-cadherin loss rather than beta-catenin alterations is a common feature of poorly differentiated thyroid carcinomas Histopathology 42 580 7
18. P Soares G Berx F van Roy M Sobrinho-Simoes 1997 E-cadherin gene alterations are rare events in thyroid tumors Int J Cancer 70 32 8
19. JR Graff VE Greenberg JG Herman WH Westra ER Boghaert KB Ain M Saji MA Zeiger SG Zimmer SB Baylin 1998 Distinct patterns of E-cadherin CpG island methylation in papillary, follicular, Hurthle's cell and poorly differentiated human thyroid carcinoma Cancer Res 58 2063 6
20. JS Nam S Hirohashi LM Wakefield 2007 Dysadherin: a new player in cancer progression Cancer Lett 255 161 9
21. X Fu MP Kamps 1991 E2A-Pbx1 induces aberrant expression of tissue specific and developmentally regulated genes when expressed in NIH 3T3 fibroblasts Mol Cel Biol 17 1503 12
22. A Batistatou D Peschos H Tsanou A Charalabopoulos Y Nakanishi S Hirohashi NJ Agnantis K Charalabopoulos 2007 In breast carcinoma dysadherin expression is correlated with invasiveness but not with E-cadherin Br J Cancer 96 1404 8
23. Y Shimada S Yamasaki Y Hashimoto T Ito J Kawamura T Soma Y Ino Y Nakanishi M Sakamoto S Hirohashi M Imamura 2004 Clinical significance of dysadherin expression in gastric cancer patients Clin Cancer Res 10 2818 23
24. S Aoki T Shimamura T Shibata Y Nakanishi Y Moriya Y Sato M Kitajima M Sakamoto S Hirohashi 2003 Prognostic significance of dysadherin expression in advanced colorectal carcinoma Br J Cancer 88 726 32
25. A Batistatou A Charalabopoulos CD Scopa Y Nakanishi A Kappas S Hirohashi NJ Agnantis K Charalabopoulos 2006 Expression patterns of dysadherin and E-cadherin in lymph node metastases of colorectal carcinoma Virchows Arch 448 763 7
26. T Shimamura T Sakamoto Y Ino 2003 Dysadherin overexpression in pancreatic ductal adenocarcinoma reflects tumor aggressiveness: relationship to E-cadherin expression J Clin Oncol 21 659 67
27. Y Shimada Y Hashimoto T Kan J Kawamura T Okumura T Soma K Kondo N Teratani G Watanabe Y Ino M Sakamoto S Hirohashi M Imamura 2004 Prognostic significance of dysadherin expression in esophageal squamous cell carcinoma Oncology 67 73 80
28. H Sato Y Ino A Miura Y Abe H Sakai K Ito S Hirohashi 2003 Dysadherin: expression and clinical significance in thyroid carcinoma J Clin Endocrinol Metabol 88 4407 12
29. Y Nakanishi S Akimoto Y Sato Y Kanai M Sakamoto S Hirohashi 2004 Prognostic significance of dysadherin expression in tongue cancer: immunohistochemical analysis of 91 cases Appl Immunohistochem Mol Morphol 12 323 8
30. P Kyzas D Stefanou A Batistatou NJ Agnantis Y Nakanishi S Hirohashi K Charalabopoulos 2006 Dysadherin expression in head and neck squamous cell carcinoma: association with lymphagiogenesis and prognostic significance Am J Surg Pathol 39 185 93
31. A Batistatou CD Scopa P Ravazoula Y Nakanishi D Peschos NJ Agnantis S Hirohashi KA Charalabopoulos 2005 Involvement of dysadherin and E-cadherin in the development of testicular tumors Br J Cancer 93 1382 7
32. D Wu Y Qiao GB Kristensen S Li G Troen R Holm JM Nesland Z Suo 2004 Prognostic significance of dysadherin expression in cervical squamous cell carcinoma Pathol Oncol Res 10 212 8
33. A Nishizawa K Nakanishi Y Yoshimura Y Sasajima N Yamazaki A Yamamoto K Hanada Y Kanai S Hirohashi 2005 Clinicopathologic significance of dysadherin expression in cutaneous malignant melanoma Cancer 103 1693 1700
34. J-S Nam M-J Kang A Suchar T Shimamura EA Kohn AM Michalowska VC Jordan S Hirohashi LM Wakefield 2006 Chemokine (C-C motif) ligand 2 mediates the prometastatic effect of dysadherin in human breast cancer cells Cancer Res 66 7176 84
35. ML Khoo S Ezzat JL Freeman SL Asa 2002 Cyclin D1 protein expression predicts metastatic behavior in thyroid papillary microcarcinomas but is not associated with gene amplification J Clin Endocrinol Metabol 87 1810 3
36. Y Ito H Yoshida T Uruno K Nakano Y Takamura A Miya K Kobayashi T Yokozawa F Matsuzuka K Kuma A Miyauchi 2003 p130 expression in thyroid neoplasms: its linkage with tumor size and dedifferentiation Cancer Lett 192 83 7
37. Y Ito T Suzuki H Yoshida C Tomoda T Uruno Y Takamura A Miya K Kobayashi F Matsuzuka K Kuma T Yamamoto A Miyauchi 2005 Phosphorylation and inactivation of Tob contributes to the progression of papillary carcinoma of the thyroid Cancer Lett 220 237 42
38. MLC Khoo NJP Beasley S Ezzat JL Freeman SL Asa 2002 Overexpression of cyclin D1 and underexpression of p27 predict lymph node metastases in papillary thyroid carcinoma J Clin Endocrinol Metabol 87 1814 8
39. A Batistatou V Zolota CD Scopa 2002 S-100 protein + dendritic cells and CD34+ dendritic interstitial cells in thyroid lesions Endocr Pathol 13 111 5